4.7 Article

Synergistic effect of CD47 blockade in combination with cordycepin treatment against cancer

Related references

Note: Only part of the references are listed.
Article Hematology

Targeting macrophages for enhancing CD47 blockade-elicited lymphoma clearance and overcoming tumor-induced immunosuppression

Xu Cao et al.

Summary: This study identifies a novel and effective strategy for treating late-stage non-Hodgkin lymphoma by remodeling the tumor microenvironment to enhance the tumoricidal effects of tumor-associated macrophages (TAMs). The study also characterizes TAM subgroups that determine the efficiency of lymphoma phagocytosis in the tumor microenvironment, which can be potential therapeutic targets to unleash the antitumor activities of macrophages.

BLOOD (2022)

Article Oncology

Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy

Claire N. Harrison et al.

Summary: This phase II trial investigated the efficacy and safety of adding BCL-XL/BCL-2 inhibitor navitoclax to ruxolitinib therapy in patients with myelofibrosis. The results showed that the addition of navitoclax resulted in durable spleen volume reduction, improved symptoms, increased hemoglobin levels, and positive effects on bone marrow fibrosis.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

Johanna Theruvath et al.

Summary: The combination of anti-GD2 and CD47 blockade demonstrates robust anti-tumor activity in mouse models, particularly effective against neuroblastoma, osteosarcoma, and small-cell lung cancer.

NATURE MEDICINE (2022)

Review Immunology

CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies

Timothy N. J. Bullock

Summary: Advances in checkpoint blockade immunotherapies have led to an expansion in methods for promoting T cell access to the tumor microenvironment, with dendritic cells playing a crucial role in the immune response to tumor antigens. The role of CD40 as a master regulator of dendritic cell activation in cancer vaccines and other immune-oncology approaches is highlighted and evaluated.

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

Article Hematology

Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL

Kristina Mueller et al.

Summary: This study suggests that combining CD47 blockade with Dara is a promising therapy for T-ALL, especially for relapsed/refractory disease harboring a dismal prognosis in patients.

BLOOD (2022)

Article Immunology

Cordycepin enhances anti-tumor immunity in colon cancer by inhibiting phagocytosis immune checkpoint CD47 expression

Qifeng Deng et al.

Summary: Cordycepin is an extract from Cordyceps militaris that has been shown to have anti-inflammatory and anti-tumor properties without toxicity. It inhibits the growth and migration of colon cancer cells and promotes apoptosis in a dose-dependent manner. Cordycepin modulates the tumor immune microenvironment, increasing the number of CD4+ T cells, CD8+ T cells, M1 type macrophages, and NK cells. It also reduces the expression of CD47 and TSP1, allowing for enhanced phagocytosis of cancer cells by macrophages. Cordycepin may be a potential immunotherapeutic drug for colon cancer.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Article Pharmacology & Pharmacy

Cordycepin alleviated metabolic inflammation in Western diet-fed mice by targeting intestinal barrier integrity and intestinal flora

Jiemei Chen et al.

Summary: Cordycepin has been found to alleviate metabolic inflammation and improve obesity-related symptoms through regulating intestinal barrier function and intestinal flora.

PHARMACOLOGICAL RESEARCH (2022)

Article Oncology

Cordycepin Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Regulating EMT-TFs SLUG, TWIST1, SNAIL1, and ZEB1

Chunli Wei et al.

Summary: Cancer metastasis is a leading cause of cancer-related death, and this study demonstrates that cordycepin (CD), a compound found in the Cordyceps mushroom, has antimetastatic effects in triple-negative breast cancer (TNBC) by inhibiting the epithelial-to-mesenchymal transition (EMT) process. CD inhibits cell growth, migration, and invasion by inactivating EMT signaling pathways and reducing the expression of specific EMT-inducing transcription factors (EMT-TFs) such as TWIST1 and SLUG. In vivo studies in mice also reveal the inhibitory effect of CD on cancer cell growth and metastasis. Additionally, combination treatment with thymoquinone (TQ), another natural product with promising anticancer properties, shows additive or synergistic anti-metastasis effects.

FRONTIERS IN ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

Cordycepin Inhibits Growth and Metastasis Formation of MDA-MB-231 Xenografts in Nude Mice by Modulating the Hedgehog Pathway

Wenya Wu et al.

Summary: This study validates the inhibitory effect of cordycepin on the growth and metastasis formation of triple-negative breast cancer (TNBC) through the Hedgehog pathway in vivo. Cordycepin reduces the volume and weight of MDA-MB-231 xenografts and affects the expression of proteins related to proliferation, apoptosis, epithelial-mesenchymal transition, and matrix metalloproteinases without side effects.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration

Mingsu Shi et al.

Summary: High CD47 expression in gastric cancer patients indicates poor prognosis and resistance to fluorouracil-based adjuvant chemotherapy (ACT). There is a positive correlation between M1-polarized macrophages infiltration and CD47 expression in gastric cancer, however, the prognostic value of M1-polarized macrophages is dampened in CD47-high gastric cancer patients.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Article Cell Biology

Efferocytosis induces macrophage proliferation to help resolve tissue injury

Brennan D. Gerlach et al.

Summary: This study demonstrates that nucleotides derived from apoptotic cell DNA hydrolysis by phagolysosomal DNase2a activate a pathway promoting non-inflammatory macrophage proliferation. The findings suggest that these nucleotides can amplify the resolution benefit by increasing the number of efferocytosing macrophages, thus enhancing tissue resolution in various experimental models including peritonitis, thymocyte apoptosis, and atherosclerosis regression.

CELL METABOLISM (2021)

Article Oncology

SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells

Siret Tahk et al.

Summary: The SIRP alpha-alpha CD123 fusion antibodies show promising therapeutic effects for AML by combining local CD47 blockade with specific LSC targeting, effectively eliminating AML LSCs while minimizing the risk of targeting healthy cells.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Cell Biology

Cordycepin Reverses Cisplatin Resistance in Non-small Cell Lung Cancer by Activating AMPK and Inhibiting AKT Signaling Pathway

Xiao-Zhong Liao et al.

Summary: The study demonstrates that the combination of cordycepin (Cor) and cisplatin (DDP) has a synergistic effect on inhibiting proliferation and promoting apoptosis of non-small cell lung cancer (NSCLC) cells. The synergistic actions are associated with the activation of AMPK and inhibition of the AKT pathway. This combination therapy may offer a new therapeutic option for DDP-resistant NSCLC.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Gastroenterology & Hepatology

Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway

Tian Lan et al.

Summary: The study demonstrates that cordycepin has significant inhibitory effects on lipid accumulation, inflammation, and fibrosis development in liver cells. By activating the AMPK signaling pathway, cordycepin can effectively protect mice under metabolic stress from hepatic steatosis, inflammation, liver injury, and fibrosis.

HEPATOLOGY (2021)

Review Pharmacology & Pharmacy

Cordyceps spp.: A Review on Its Immune-Stimulatory and Other Biological Potentials

Gitishree Das et al.

Summary: Interest in the Cordyceps genus has increased due to its immunostimulatory potential, with various pharmacological activities reported in pre-clinical studies. The bioactive compounds present in Cordyceps have been linked to its diverse properties, including immune stimulation and potential therapeutic benefits.

FRONTIERS IN PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment

Mauro Di Pilato et al.

Summary: The conversion of stem-like CTLs into effector-like CTLs involves chemotactic reprogramming with upregulation of chemokine receptor CXCR6. CXCR6 expression and IL-15 trans-presentation are crucial for the survival and local expansion of effector-like CTLs in the tumor microenvironment.
Article Cell Biology

CCL7 contributes to angiotensin II-induced abdominal aortic aneurysm by promoting macrophage infiltration and pro-inflammatory phenotype

Cuiping Xie et al.

Summary: CCL7 promotes the formation of AAA induced by Ang II by promoting M1 phenotype of macrophages through the CCR1/JAK2/STAT1 signaling pathway. Administration of CCL7-neutralizing antibody can significantly attenuate the development and pathological changes of AAA.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Immunology

Cordycepin confers long-term neuroprotection via inhibiting neutrophil infiltration and neuroinflammation after traumatic brain injury

Pengju Wei et al.

Summary: The study demonstrates that cordycepin can protect neurological function by suppressing neutrophil infiltration, preserving blood-brain barrier integrity, and altering microglia/macrophage polarization after traumatic brain injury.

JOURNAL OF NEUROINFLAMMATION (2021)

Article Nanoscience & Nanotechnology

Time-Programmed Delivery of Sorafenib and Anti-CD47 Antibody via a Double-Layer-Gel Matrix for Postsurgical Treatment of Breast Cancer

Liping Huang et al.

Summary: A novel therapy system with programmable delivery function was developed to achieve time-programmed sequential delivery of combined cancer immunotherapy. By loading drugs in different layers of gel matrix, it efficiently prevented tumor recurrence and metastasis in breast cancer patients.

NANO-MICRO LETTERS (2021)

Article Pharmacology & Pharmacy

Cordycepin Inhibits Cancer Cell Proliferation and Angiogenesis through a DEK Interaction via ERK Signaling in Cholangiocarcinoma

Tesi Liu et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)

Article Multidisciplinary Sciences

Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction

Mingzhu Yin et al.

NATURE COMMUNICATIONS (2020)

Article Chemistry, Multidisciplinary

Activating Macrophage-Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles

Lang Rao et al.

ADVANCED MATERIALS (2020)

Review Immunology

Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis

Jinyang Hu et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Cell Biology

Cordyceps militaris Improves Chronic Kidney Disease by Affecting TLR4/NF-kappa B Redox Signaling Pathway

Tingli Sun et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)

Article Medicine, Research & Experimental

Fbxw7 increases CCL2/7 in CX3CR1hi macrophages to promote intestinal inflammation

Jia He et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Nanoscience & Nanotechnology

In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment

Qian Chen et al.

NATURE NANOTECHNOLOGY (2019)

Article Engineering, Biomedical

A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer

Ashish Kulkarni et al.

NATURE BIOMEDICAL ENGINEERING (2018)

Article Medicine, General & Internal

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma

Ranjana Advani et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Oncology

Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers

Concetta Di Mauro et al.

BRITISH JOURNAL OF CANCER (2017)

Article Medicine, Research & Experimental

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer

Kipp Weiskopf et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Food Science & Technology

Anti-cancer effect and apoptosis induction of cordycepin through DR3 pathway in the human colonic cancer cell HT-29

Seung Yuan Lee et al.

FOOD AND CHEMICAL TOXICOLOGY (2013)

Article Gastroenterology & Hepatology

Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1

Jamie L. McClellan et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)

Article Pharmacology & Pharmacy

Cordycepin-induced apoptosis and autophagy in breast cancer cells are independent of the estrogen receptor

Sunga Choi et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)

Review Oncology

Cancer related inflammation: The macrophage connection

Antonio Sica et al.

CANCER LETTERS (2008)

Article Immunology

A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo

M Matloubian et al.

NATURE IMMUNOLOGY (2000)